In a potential breakthrough for cancer treatment, a new medication priced at only Rs 100 has captured attention, offering hope for affordable and accessible options.

Sonal Mehrotra Kapoor engages in a conversation with Dr. Prashant Mehta, an Oncologist, to explore the possibilities and challenges associated with this seemingly revolutionary pill.

Dr. Mehta emphasizes the need for cautious optimism, stating that while the initial findings are promising, it is still too early to determine the medication's effectiveness. Currently undergoing animal testing, the anti-cancer pill has yet to undergo the rigorous testing phases required for human use.

The prospect of a low-cost anti-cancer medicine has raised hopes for patients facing the financial burden of expensive treatments. However, the medical community underscores the importance of thorough testing to ensure the safety and efficacy of the medication.

As the world eagerly awaits the outcome of further research, the potential affordability of this anti-cancer pill could mark a significant milestone in the ongoing battle against cancer. The medical community, patients, and advocates are closely watching for updates on the progress of this groundbreaking development.